In fact, patients who control KS have more polyfunctional CD8+ T cells producing IFN-γ and TNF-α, while patients with progressive KS have weaker and less polyfunctional HHV-8-specific CD8+ T cells (Bihl et al., 2009). The gene discussed is CD8A; the disease is Kaposi's sarcoma.